217 related articles for article (PubMed ID: 28622999)
21. Editorial: mRNA Vaccines and Future Epidemic, Pandemic, and Endemic Zoonotic Virus Infections.
Parums DV
Med Sci Monit; 2021 May; 27():e932915. PubMed ID: 33942804
[TBL] [Abstract][Full Text] [Related]
22. Hatchery Vaccination Against Poultry Viral Diseases: Potential Mechanisms and Limitations.
Abdul-Cader MS; Palomino-Tapia V; Amarasinghe A; Ahmed-Hassan H; De Silva Senapathi U; Abdul-Careem MF
Viral Immunol; 2018; 31(1):23-33. PubMed ID: 28714781
[TBL] [Abstract][Full Text] [Related]
23. Editorial overview: Virus reverse genetics approaches for the development of preventive and therapeutic vaccines.
Martinez-Sobrido L; Nogales A
Curr Opin Virol; 2020 Oct; 44():iii-iv. PubMed ID: 33349418
[No Abstract] [Full Text] [Related]
24. Wanted, dead or alive: new viral vaccines.
Amanna IJ; Slifka MK
Antiviral Res; 2009 Nov; 84(2):119-30. PubMed ID: 19733596
[TBL] [Abstract][Full Text] [Related]
25. Ethics of vaccination programs.
Schwartz JL; Caplan AL
Curr Opin Virol; 2011 Oct; 1(4):263-7. PubMed ID: 22440783
[TBL] [Abstract][Full Text] [Related]
26. [Current vaccination strategies].
Dietz K
Internist (Berl); 1992 Sep; 33(9):575-80. PubMed ID: 1399392
[No Abstract] [Full Text] [Related]
27. Animal vaccination and the evolution of viral pathogens.
Schat KA; Baranowski E
Rev Sci Tech; 2007 Aug; 26(2):327-38. PubMed ID: 17892155
[TBL] [Abstract][Full Text] [Related]
28. Problems in developing a respiratory vaccine.
Chang TW
N Engl J Med; 1970 Dec; 283(23):1287. PubMed ID: 5476483
[No Abstract] [Full Text] [Related]
29. Vaccines, vaccination, and vaccinology.
Plotkin SA
J Infect Dis; 2003 May; 187(9):1349-59. PubMed ID: 12717615
[No Abstract] [Full Text] [Related]
30. Vaccines against respiratory viral pathogens for use in neonates: opportunities and challenges.
Alexander-Miller MA
J Immunol; 2014 Dec; 193(11):5363-9. PubMed ID: 25411431
[TBL] [Abstract][Full Text] [Related]
31. The status of live viral vaccination in early life.
Gans HA
Vaccine; 2013 May; 31(21):2531-7. PubMed ID: 23026688
[TBL] [Abstract][Full Text] [Related]
32. T cell sensitivity and the outcome of viral infection.
Walker LJ; Sewell AK; Klenerman P
Clin Exp Immunol; 2010 Mar; 159(3):245-55. PubMed ID: 19968665
[TBL] [Abstract][Full Text] [Related]
33. Viral vaccines: selected topics.
Kańtoch M
Arch Immunol Ther Exp (Warsz); 1996; 44(5-6):367-71. PubMed ID: 9017153
[TBL] [Abstract][Full Text] [Related]
34. Innate and adaptive immune responses to viral infection and vaccination.
Aoshi T; Koyama S; Kobiyama K; Akira S; Ishii KJ
Curr Opin Virol; 2011 Oct; 1(4):226-32. PubMed ID: 22440781
[TBL] [Abstract][Full Text] [Related]
35. Viral vectors for use in the development of biodefense vaccines.
Lee JS; Hadjipanayis AG; Parker MD
Adv Drug Deliv Rev; 2005 Jun; 57(9):1293-314. PubMed ID: 15935875
[TBL] [Abstract][Full Text] [Related]
36. Clinical pharmacology and viral infections.
Reynolds KS
Clin Pharmacol Ther; 2010 Nov; 88(5):569-73. PubMed ID: 20959836
[No Abstract] [Full Text] [Related]
37. Longitudinal profiling of the vaccination coverage in Brazil reveals a recent change in the patterns hallmarked by differential reduction across regions.
Césare N; Mota TF; Lopes FFL; Lima ACM; Luzardo R; Quintanilha LF; Andrade BB; Queiroz ATL; Fukutani KF
Int J Infect Dis; 2020 Sep; 98():275-280. PubMed ID: 32619762
[TBL] [Abstract][Full Text] [Related]
38. [Achievements and prospects of the specific prophylaxis of viral diseases].
Andzhaparidze OG
Vestn Akad Med Nauk SSSR; 1983; (12):3-8. PubMed ID: 6666317
[No Abstract] [Full Text] [Related]
39. Novel vaccine strategies against emerging viruses.
García-Sastre A; Mena I
Curr Opin Virol; 2013 Apr; 3(2):210-6. PubMed ID: 23477832
[TBL] [Abstract][Full Text] [Related]
40. Genital delivery of virus-like particle and pseudovirus-based vaccines.
Cuburu N; Chackerian B
Expert Rev Vaccines; 2011 Sep; 10(9):1245-8. PubMed ID: 21919611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
